Aktiesnakken — Juni 2011
-
hvis du kigger på indekset over biotek OMX, så vil du se at ALT biotek er ramt
-
lige fra LCP, Zealand Pharma til Genmab
-
Bava, Neuro, Topo, Affitech
-
you name it - its hammered
-
new york pliiing
-
ja det tror jeg
-
we´re still here
-
Genmab er da utroligt tæt på at blive en kommerciel succes. Der mangler måske et par indikationer, så kører bussen
-
jeg må bare for egen regning insisterer på at jeg hellere vil være med i et biotekselskab der har et stof på markedet end et der ikke har.
-
ja jeg skal ikke overtale nogen
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind